Mission GBM
Subscribe
Sign in
Home
Glossary of Terms
Brain Cancer News
Brain Cancer Science Talk
Clinical Trials
FAQs
Goals of Care
Investing in Brain Cancer
Julie's Journey
Meet the Team
Archive
About
Latest
Top
Breaking News: FDA Approves Vorasidenib (Voranigo®)
A great day for Low Grade Astrocytoma and Oligodendroglioma Patients with IDH1/IDH2 Mutations
Aug 6
•
Scott L. Rakestraw, PhD
7
Share this post
Breaking News: FDA Approves Vorasidenib (Voranigo®)
www.missiongbm.com
Copy link
Facebook
Email
Note
Other
July 2024
Postcards from the Field
Some green shoots of investing progress as MissionGBM welcomes its 300th case
Jul 30
•
Scott L. Rakestraw, PhD
9
Share this post
Postcards from the Field
www.missiongbm.com
Copy link
Facebook
Email
Note
Other
Michael Lim, MD – Brain Cancer Science Talk (Episode 7)
Stanford’s Chair of Neurosurgery discusses the promise and challenges associated with immunotherapy for brain tumors
Jul 15
•
Scott L. Rakestraw, PhD
6
Share this post
Michael Lim, MD – Brain Cancer Science Talk (Episode 7)
www.missiongbm.com
Copy link
Facebook
Email
Note
Other
30:07
The Reality of Clinical Trials – Part 2
Bess Stillman, MD details how the Regulatory process needs to be modernized to better serve both cancer patients and Sponsors. We extend the concepts to…
Jul 2
•
Scott L. Rakestraw, PhD
4
Share this post
The Reality of Clinical Trials – Part 2
www.missiongbm.com
Copy link
Facebook
Email
Note
Other
June 2024
ASCO 2024: Brain Cancer Highlights
A few potential gems begin to sparkle
Jun 20
•
Scott L. Rakestraw, PhD
2
Share this post
ASCO 2024: Brain Cancer Highlights
www.missiongbm.com
Copy link
Facebook
Email
Note
Other
Anniversary Post: 35 Years, 918 Days…and Counting
A Brain Cancer Diagnosis Can Be a Catalyst to Celebrate Life
Jun 10
•
Scott L. Rakestraw, PhD
17
Share this post
Anniversary Post: 35 Years, 918 Days…and Counting
www.missiongbm.com
Copy link
Facebook
Email
Note
Other
David D. Tran, MD, PhD – Brain Cancer Science Talk (Episode 6)
An Open-Minded and Curious Physician/Scientist Follows the #Data to Innovate a Compelling Protocol for Treating Gliomas
Jun 5
•
Scott L. Rakestraw, PhD
4
Share this post
David D. Tran, MD, PhD – Brain Cancer Science Talk (Episode 6)
www.missiongbm.com
Copy link
Facebook
Email
Note
Other
58:11
Glossary of Terms
A Reader-Requested Roadmap of the MissionGBM Abbreviations and Acronyms
Jun 3
•
Scott L. Rakestraw, PhD
1
Share this post
Glossary of Terms
www.missiongbm.com
Copy link
Facebook
Email
Note
Other
May 2024
Paul S. Mischel, MD – Brain Cancer Science Talk (Episode 5)
ecDNA, the Importance of Science, #Data and Collaboration, and Upgrading Science in Neuro-Oncology
May 30
•
Scott L. Rakestraw, PhD
2
Share this post
Paul S. Mischel, MD – Brain Cancer Science Talk (Episode 5)
www.missiongbm.com
Copy link
Facebook
Email
Note
Other
43:30
Meet the Team – Paul S. Mischel, MD
World Class Molecular Oncologist, Invaluable Thought Partner and Complete Mensch
May 23
•
Scott L. Rakestraw, PhD
6
Share this post
Meet the Team – Paul S. Mischel, MD
www.missiongbm.com
Copy link
Facebook
Email
Note
Other
News: Erasca Reorganizes and Deprioritizes Development of ERAS-801 for rGBM
Yet Another EGFR-targeted Monotherapy Drops Anchor
May 17
•
Scott L. Rakestraw, PhD
3
Share this post
News: Erasca Reorganizes and Deprioritizes Development of ERAS-801 for rGBM
www.missiongbm.com
Copy link
Facebook
Email
Note
Other
Samuel Blackman, MD, PhD – Brain Cancer Science Talk (Episode 4)
Physician, Scientist, Entrepreneur…and Humanitarian
May 15
•
Scott L. Rakestraw, PhD
1
Share this post
Samuel Blackman, MD, PhD – Brain Cancer Science Talk (Episode 4)
www.missiongbm.com
Copy link
Facebook
Email
Note
Other
36:15
Share
Copy link
Facebook
Email
Note
Other
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts
